ADAR1 Capital Management »

Ea Series Trust shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Ea Series Trust (BOXX) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Ea Series Trust

Tip: Access up to 7 years of quarterly data

All positions including Ea Series Trust held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ea Series Trust by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $35M 323k 108.93
2024-06-30 $38M 352k 107.82
2024-03-31 $34M 318k 106.46

More positions owned by ADAR1 Capital Management

Cytokinetics Com New (CYTK)
Protagonist Therapeutics (PTGX)
Bridgebio Pharma (BBIO)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Royalty Pharma Shs Class A (RPRX)
Keros Therapeutics (KROS)
Ascendis Pharma A/s Sponsored Adr (ASND)
Zura Bio Class A Ord Shs (ZURA)
Zai Lab Adr (ZLAB)
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Aa Mission Acquisition Corp Ord Shs Cl A (AAM)
Mineralys Therapeutics (MLYS)
Syndax Pharmaceuticals (SNDX)

View all positions for ADAR1 Capital Management

Top funds holding Ea Series Trust

Wealth Enhancement Advisory Services
Renaissance Technologies
Lgl Partners
True Wealth Design
Rockefeller Capital Management
Cambridge Investment Research Advisors
Mariner Wealth Advisors
Ethos Financial Group
ADAR1 Capital Management
Empowered Funds
Compass Ion Advisors
Insight Advisors, LLC/ PA
Whitcomb & Hess
CWM
Stokes Family Office

View all funds holding Ea Series Trust